SK15672000A3 - Použitie paroxetínu na liečenie generalizovaných anxióznych stavov - Google Patents

Použitie paroxetínu na liečenie generalizovaných anxióznych stavov Download PDF

Info

Publication number
SK15672000A3
SK15672000A3 SK1567-2000A SK15672000A SK15672000A3 SK 15672000 A3 SK15672000 A3 SK 15672000A3 SK 15672000 A SK15672000 A SK 15672000A SK 15672000 A3 SK15672000 A3 SK 15672000A3
Authority
SK
Slovakia
Prior art keywords
paroxetine
treatment
pharmaceutically acceptable
generalized anxiety
acceptable salt
Prior art date
Application number
SK1567-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Rocco Zaninelli
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of SK15672000A3 publication Critical patent/SK15672000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1567-2000A 1998-04-22 1999-04-22 Použitie paroxetínu na liečenie generalizovaných anxióznych stavov SK15672000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment
PCT/US1999/008786 WO1999053919A1 (fr) 1998-04-22 1999-04-22 Traitement de trouble anxieux generalise avec de la paroxetine

Publications (1)

Publication Number Publication Date
SK15672000A3 true SK15672000A3 (sk) 2001-04-09

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1567-2000A SK15672000A3 (sk) 1998-04-22 1999-04-22 Použitie paroxetínu na liečenie generalizovaných anxióznych stavov

Country Status (20)

Country Link
EP (1) EP1073437A4 (fr)
JP (1) JP2002512189A (fr)
KR (1) KR20010034817A (fr)
CN (1) CN1298301A (fr)
AP (1) AP2000001959A0 (fr)
AU (1) AU3864899A (fr)
BG (1) BG104939A (fr)
BR (1) BR9909791A (fr)
CA (1) CA2328896A1 (fr)
CZ (1) CZ20003885A3 (fr)
EA (1) EA200001088A1 (fr)
GB (1) GB9808479D0 (fr)
HU (1) HUP0101350A3 (fr)
ID (1) ID27546A (fr)
IL (1) IL139167A0 (fr)
NO (1) NO20005286L (fr)
PL (1) PL343494A1 (fr)
SK (1) SK15672000A3 (fr)
TR (1) TR200003082T2 (fr)
WO (1) WO1999053919A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
CN1298301A (zh) 2001-06-06
BG104939A (bg) 2001-09-28
ID27546A (id) 2001-04-12
CA2328896A1 (fr) 1999-10-28
BR9909791A (pt) 2000-12-26
EP1073437A1 (fr) 2001-02-07
JP2002512189A (ja) 2002-04-23
NO20005286D0 (no) 2000-10-20
PL343494A1 (en) 2001-08-27
WO1999053919A1 (fr) 1999-10-28
TR200003082T2 (tr) 2001-01-22
KR20010034817A (ko) 2001-04-25
GB9808479D0 (en) 1998-06-17
NO20005286L (no) 2000-12-20
HUP0101350A3 (en) 2002-06-28
EA200001088A1 (ru) 2001-04-23
EP1073437A4 (fr) 2003-04-16
AU3864899A (en) 1999-11-08
HUP0101350A2 (hu) 2002-05-29
IL139167A0 (en) 2001-11-25
AP2000001959A0 (en) 2000-12-31
CZ20003885A3 (cs) 2001-09-12

Similar Documents

Publication Publication Date Title
US5371092A (en) Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
CA2608024A1 (fr) Utilisation de la flibanserine dans le traitement de la douleur chronique
US4804669A (en) Treatment of pain with a piperidine
US6121291A (en) Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder
US6372763B1 (en) Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (SSRI)
SK15672000A3 (sk) Použitie paroxetínu na liečenie generalizovaných anxióznych stavov
US4363809A (en) Organic compounds
SK19192000A3 (sk) Použitie paroxetínu alebo jeho farmaceuticky prijateľnej soli alebo solvátu na podporu odvykania od fajčenia alebo na zníženie alebo prevenciu relapsu fajčenia
US4105796A (en) Pharmaceutical compositions containing racemic or optically active 1-(2,6-dimethyl-phenoxy)-2-methylamino-propane and method of use
MXPA00010343A (en) Treatment of generalized anxiety disorder with paroxetine
KR20010071893A (ko) 치료 방법
MXPA00000522A (en) Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)
CZ200085A3 (cs) Léčivo proti srdečním poruchám a farmaceutický prostředek s obsahem SSRI
IE43955B1 (en) Pharmaceutical composition and dosage units thereof
GB2219939A (en) Use of a thromboxane receptor antagonist in renal diseases and dysfunction
GB2301774A (en) Piperidine derivatives as 5-HT-2C receptor antagonists